METAVIA INC. Adjustments to Additional Paid in Capital, Warrant Issued
METAVIA INC. (MTVA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $309.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-26
- METAVIA INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-06-30 was $309.00K.
- METAVIA INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-09-30 was $196.00K, a 25.64% increase year-over-year.
- METAVIA INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2017-09-30 was $156.00K.
- METAVIA INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $309.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2024-12-31 | $309.00K 10-K · filed 2026-03-26 | |
| 2024-06-30 | $309.00K 10-Q · filed 2025-11-06 | |
| 2018-09-30 | $196.00K 10-Q · filed 2018-11-08 | |
| 2017-09-30 | $156.00K 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |